Published in Neuroscience on February 04, 2010
Detecting disease-associated genes with confounding variable adjustment and the impact on genomic meta-analysis: with application to major depressive disorder. BMC Bioinformatics (2012) 1.46
Analyzing schizophrenia by DNA microarrays. Biol Psychiatry (2011) 1.16
Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry (2012) 1.06
The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis (2011) 0.95
Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. BMC Neurosci (2013) 0.90
A FreeSurfer view of the cortical transcriptome generated from the Allen Human Brain Atlas. Front Neurosci (2015) 0.82
Meta-Analysis of Gene Expression in Autism Spectrum Disorder. Autism Res (2015) 0.81
Meta-analysis of sex differences in gene expression in schizophrenia. BMC Syst Biol (2016) 0.77
Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia. Schizophr Res (2016) 0.75
Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies. BMC Neurol (2017) 0.75
Age-Related Gene Expression in the Frontal Cortex Suggests Synaptic Function Changes in Specific Inhibitory Neuron Subtypes. Front Aging Neurosci (2017) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
Multiple-laboratory comparison of microarray platforms. Nat Methods (2005) 11.74
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A (2004) 9.42
Gene regulation and DNA damage in the ageing human brain. Nature (2004) 9.01
Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol (2006) 8.87
Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res (2002) 7.29
ErmineJ: tool for functional analysis of gene expression data sets. BMC Bioinformatics (2005) 4.98
Neuregulins: functions, forms, and signaling strategies. Exp Cell Res (2003) 4.62
Regional patterns of gene expression in human and chimpanzee brains. Genome Res (2004) 3.84
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res (2005) 3.79
Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics (2009) 3.50
Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics (2006) 3.40
DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One (2007) 3.30
Using RNA sample titrations to assess microarray platform performance and normalization techniques. Nat Biotechnol (2006) 3.13
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53
Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology (2004) 2.48
The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett (1995) 2.35
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet (2004) 2.33
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet (2004) 2.31
Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A (2008) 2.29
Three microarray platforms: an analysis of their concordance in profiling gene expression. BMC Genomics (2005) 2.29
Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci (2004) 2.28
Evolution of the aging brain transcriptome and synaptic regulation. PLoS One (2008) 2.23
Meta-analysis of microarray results: challenges, opportunities, and recommendations for standardization. Gene (2007) 2.16
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry (2005) 2.06
Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings. Aging Cell (2008) 1.88
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79
Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res (2002) 1.76
The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc Natl Acad Sci U S A (2001) 1.72
Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry (2006) 1.66
Sample matching by inferred agonal stress in gene expression analyses of the brain. BMC Genomics (2007) 1.54
Fisher's combined p-value for detecting differentially expressed genes using Affymetrix expression arrays. BMC Genomics (2007) 1.38
Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction. BMC Bioinformatics (2003) 1.36
Can subtle changes in gene expression be consistently detected with different microarray platforms? BMC Genomics (2008) 1.36
Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry (2006) 1.34
Transcriptome-wide assessment of human brain and lymphocyte senescence. PLoS One (2008) 1.33
Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res (2006) 1.31
An evolutionarily conserved sexual signature in the primate brain. PLoS Genet (2008) 1.21
Meta-analysis of 12 genomic studies in bipolar disorder. J Mol Neurosci (2007) 1.12
Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. Brain Struct Funct (2008) 1.06
Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry (2008) 1.00
Microarray platform consistency is revealed by biologically functional analysis of gene expression profiles. BMC Bioinformatics (2009) 0.98
MAID : an effect size based model for microarray data integration across laboratories and platforms. BMC Bioinformatics (2008) 0.97
Taurine improves learning and retention in aged mice. Neurosci Lett (2008) 0.93
Confirmation of region-specific patterns of gene expression in the human brain. Neurogenetics (2007) 0.91
Glutamic acid decarboxylase 67 (GAD67) gene expression in discrete regions of the rostral preoptic area change during the oestrous cycle and with age. J Neuroendocrinol (2004) 0.86
Reciprocal phylogenetic conservation of molecular aging in mouse and human brain. Neurobiol Aging (2009) 0.86
Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS. J Neurosci (2000) 3.96
Molecular differences between chronic and aggressive periodontitis. J Dent Res (2013) 1.66
Pair recordings reveal all-silent synaptic connections and the postsynaptic expression of long-term potentiation. Neuron (2001) 1.58
Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension. J Hum Hypertens (2008) 1.54
Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritis. Rheumatology (Oxford) (2004) 1.18
OmegaPlus: a scalable tool for rapid detection of selective sweeps in whole-genome datasets. Bioinformatics (2012) 1.13
Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry (2012) 1.06
Outcome of array CGH analysis for 255 subjects with intellectual disability and search for candidate genes using bioinformatics. Hum Genet (2010) 0.97
Immature malignant sacrococcygeal teratoma: case report and review of the literature. Clin Exp Obstet Gynecol (2013) 0.94
Giant abdominal aortic aneurysms: clinical and technical considerations. Acta Chir Belg (2009) 0.92
A high-throughput study of gene expression in preterm labor with a subtractive microarray approach. Am J Obstet Gynecol (2001) 0.92
Bioinformatic analysis of autism positional candidate genes using biological databases and computational gene network prediction. Genes Brain Behav (2003) 0.89
Gingival tissue transcriptomes identify distinct periodontitis phenotypes. J Dent Res (2014) 0.87
Granulocyte chemotactic protein 2 (gcp-2/cxcl6) complements interleukin-8 in periodontal disease. J Periodontal Res (2008) 0.85
Basal and apical synapses of CA1 pyramidal cells employ different LTP induction mechanisms. Learn Mem (1999) 0.84
Identification of taste quality with the use of meg. J Integr Neurosci (2006) 0.78
Electrogustometry thresholds, tongue tip vascularization, and density and morphology of the fungiform papillae in diabetes. B-ENT (2014) 0.76
Misleading findings of subclavian artery and vein transection. Vasa (2007) 0.75
Femoral artery pseudoaneurysms in intravenous drug users: a 12-year series. Int Angiol (2012) 0.75
Cardiac troponin I in patients with acute upper and lower limb ischemia. Vasa (2008) 0.75
Anastomotic pseudoaneurysms: our experience with 49 cases. Ann Vasc Surg (2006) 0.75
[Transluminal treatment in aneurysm of the abdominal aorta. Role of diagnostic imaging]. Radiol Med (1999) 0.75
[Serotonin in myomas of the uterus]. Zentralbl Gynakol (1970) 0.75